Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
[Pharmacological treatment of diabetic retinopathy].

Vnitrni lekarstvi

Smahelová A.
PMID: 17642435
Vnitr Lek. 2007 May;53(5):512-20.

Diabetic retinopathy is the most serious diabetic complication. Modern pharmacotherapy offers a wide range of potential treatments (ACE inhibitors, sartans, hypolipidemic drugs, drugs influencing proteinkinase C and vascular endotelial growth factor etc.). Diabetic retinopathy was previously treated surgically but...

[New treatments for diabetic retinopathy].

Journal francais d'ophtalmologie

Massin P.
PMID: 21696846
J Fr Ophtalmol. 2011 Sep;34(7):491-7. doi: 10.1016/j.jfo.2011.04.007. Epub 2011 Jun 21.

Even if several studies have clearly demonstrated that a good control of glycemia and arterial pressure allow reducing the incidence and the progression of diabetic retinopathy, there is currently no drug treatment to prevent the incidence or progression of...

Diabetic retinopathy: how far are we from personalized medicine?.

Future medicinal chemistry

Sahajpal NS, Chaubey A, Goel RK, Jain SK.
PMID: 30215275
Future Med Chem. 2018 Oct 01;10(19):2249-2252. doi: 10.4155/fmc-2018-0233. Epub 2018 Sep 14.

No abstract available.

[Progress of research on pathogenesis and medical treatment of diabetic retinopathy].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Geng S, Ye JJ.
PMID: 18510248
Zhonghua Yan Ke Za Zhi. 2008 Jan;44(1):76-81.

Diabetic retinopathy is a common complication of diabetes mellitus. Studies on the pathogenesis of diabetic retinopathy are important for the prevention and treatment of this disease. Neurodegeneration and microvascular dysfunction are the major events of diabetic retinopathy happened in...

New pharmacologic approaches to treating diabetic retinopathy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Ryan GJ.
PMID: 17720889
Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332.

PURPOSE: The goal of treatment of diabetic retinopathy, limitations of laser photocoagulation, endpoints used in clinical studies of diabetic retinopathy treatments, and the mechanism of action, efficacy, and safety of several new and emerging therapies targeting the biochemical pathways...

Showing 1 to 5 of 5 entries